Hormonal, metabolic, and endometrial safety of testosterone vaginal cream versus estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: a randomized, placebo-controlled study
Conclusions:
Twelve weeks of treatment with topical testosterone or estrogen in postmenopausal women with symptoms of vaginal atrophy demonstrated laboratory and endometrial safety when compared with placebo.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Cholesterol | Estradiol | Hormones | Laboratory Medicine | Men | Menopause | OBGYN | Study | Women